| Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017 | 239 | 2017 |
| Use of complementary and alternative medicine by children in Europe: published data and expert perspectives TJ Zuzak, J Boňková, D Careddu, M Garami, A Hadjipanayis, J Jazbec, ... Complementary therapies in medicine 21, S34-S47, 2013 | 189 | 2013 |
| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 164 | 2017 |
| Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 157 | 2018 |
| EQ-5D in central and Eastern Europe: 2000–2015 F Rencz, L Gulácsi, M Drummond, D Golicki, V Prevolnik Rupel, J Simon, ... Quality of Life Research 25, 2693-2710, 2016 | 139 | 2016 |
| Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ... The European journal of health economics 15, 13-25, 2014 | 113 | 2014 |
| Pricing and reimbursement of biosimilars in Central and Eastern European countries P Kawalec, E Stawowczyk, T Tesar, J Skoupa, A Turcu-Stiolica, ... Frontiers in pharmacology 8, 288, 2017 | 77 | 2017 |
| Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ... Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021 | 68 | 2021 |
| Use of biologics for psoriasis in Central and Eastern European countries F Rencz, L Kemény, JZ Gajdácsi, W Owczarek, P Arenberger, GS Tiplica, ... Journal of the European Academy of Dermatology and Venereology 29 (11), 2222 …, 2015 | 60 | 2015 |
| Adaptive pathways: possible next steps for payers in preparation for their potential implementation P Vella Bonanno, M Ermisch, B Godman, AP Martin, J Van Den Bergh, ... Frontiers in pharmacology 8, 497, 2017 | 53 | 2017 |
| Pricing of oral generic cancer medicines in 25 European countries; findings and implications B Godman, A Hill, S Simoens, A Kurdi, J Gulbinovič, A Martin, A Timoney, ... Generics and Biosimilars Initiative Journal 8 (2), 49-70, 2019 | 52 | 2019 |
| Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income … B Godman, C Grobler, M Van-De-Lisle, J Wale, WB Barbosa, A Massele, ... Expert opinion on pharmacotherapy 20 (18), 2237-2255, 2019 | 50 | 2019 |
| Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy G Petrova, A Stoimenova, M Dimitrova, M Kamusheva, D Petrova, ... SAGE open medicine 5, 2050312117690404, 2017 | 49 | 2017 |
| Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria K Tachkov, K Mitov, Y Koleva, Z Mitkova, M Kamusheva, M Dimitrova, ... PloS one 15 (5), e0232815, 2020 | 47 | 2020 |
| Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ... Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019 | 46 | 2019 |
| Low fresh gas flow balanced anesthesia versus target controlled intravenous infusion anesthesia in laparoscopic cholecystectomy: a cost-minimization analysis PD Stevanovic, G Petrova, B Miljkovic, R Scepanovic, R Perunovic, ... Clinical therapeutics 30 (9), 1714-1725, 2008 | 46 | 2008 |
| Pharmaceutical regulation in Central and Eastern European countries: a current review P Kawalec, T Tesar, L Vostalova, P Draganic, M Manova, A Savova, ... Frontiers in pharmacology 8, 892, 2017 | 45 | 2017 |
| The European challenges of funding orphan medicinal products M Szegedi, T Zelei, F Arickx, A Bucsics, E Cohn-Zanchetta, J Fürst, ... Orphanet journal of rare diseases 13, 1-8, 2018 | 42 | 2018 |
| Patient access, unmet medical need, expected benefits, and concerns related to the utilisation of biosimilars in Eastern European countries: a survey of experts A Inotai, M Csanadi, G Petrova, M Dimitrova, T Bochenek, T Tesar, K York, ... BioMed Research International 2018 (1), 9597362, 2018 | 42 | 2018 |
| Complex regional pain syndrome acceptance and the alternative denominations in the medical literature J Todorova, N Dantchev, G Petrova Medical principles and practice 22 (3), 295-300, 2013 | 41 | 2013 |
Maria DimitrovaMedical University of Sofia, Faculty of Pharmacy在 pharmfac.net 的电子邮件经过验证
